Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

All Content

  • News

    Dexmedetomidine, propofol similar in ventilated adults with sepsis

    February 5, 2021

    Guidelines currently recommend either drug when light sedation is needed for adults on ventilators.

  • 1
    News

    COVID-19: Another study links colchicine to better results

    February 4, 2021

    Brazilian trial tested gout drug against placebo in hospitalized patients.

  • News

    Telehealth helps cut mortality risk among ICU patients

    February 4, 2021

    In the traditional model, critical care specialists may be on-site during the day but on call after hours.

  • 1
    News

    Regular medical masks no different than N95 respirator masks in preventing flu transmission

    February 4, 2021

    Are N95 respirator masks better than regular medical masks in preventing the transmission of influenza and other respiratory infections among health care providers?

  • News

    The Match and COVID-19: Stolen interviews, swag bags, and stress

    February 4, 2021

    “It’s really hard to get a real feel for the program when you’ve not been there in person.”

  • 1
    News

    Weekly COVID-19 cases in children continue to drop

    February 3, 2021

    Children’s share of weekly COVID-19 total increased for the fourth straight week.

  • 1
    News

    Complete PCI beats culprit-lesion-only PCI in STEMI patients with multivessel CAD

    February 3, 2021

    In patients who have a STEMI (ST elevation myocardial infarction) and are found to have multivessel coronary artery disease, does staged percutaneous coronary intervention (PCI) of nonculprit lesions improve cardiovascular death or MI?

  • News

    Microthrombi, necrosis seen in COVID-19 hearts on autopsy

    February 3, 2021

    A new autopsy series shows microthrombi and focal necrosis in hearts of patients who died of COVID-19. The findings support use of anticoagulation, but best dosing remains unclear, researchers say.

  • 1
    Opinion

    The Blitz and COVID-19

    February 3, 2021

    The psychology of those who have suffered “direct hits” or “near misses” are the daily bedside challenge of all physicians.

  • 1
    News

    DAPT increases bleeding without decreasing mortality in patients with coronary disease and diabetes

    February 2, 2021

    In patients who have diabetes with known coronary disease but without prior MI or stroke, what is the effect of dual-antiplatelet therapy (DAPT) with aspirin and ticagrelor on cardiovascular outcomes and bleeding events?

Previous1 … 69 70 71 72 73 … 861Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences